Miami Dade Medical Research Institute | ClinicalTrials HQ

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder	anxiety disorder, generalized anxiety disorder, psychiatric disorder	Recruiting	Phase 2	2026-09-25		NCT06701903
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms	depressive disorder, major depressive disorder, mood disorder, psychiatric disorder	Recruiting	Phase 3	2026-09-25		NCT06559306
Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder	anxiety disorder, generalized anxiety disorder, psychiatric disorder	Recruiting	Phase 2	2026-09-25		NCT06480383
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder	depressive disorder, major depressive disorder, mood disorder, psychiatric disorder	Recruiting	Phase 2	2026-08-03		NCT06547489
A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )	Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, fatty liver disease, liver disorder, metabolic dysfunction-associated steatohepatitis, metabolic dysfunction-associated steatotic liver disease	Active, not recruiting	Phase 3	2026-07-02		NCT04849728
A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis	Digestive System Diseases, fatty liver disease, liver disorder, metabolic dysfunction-associated steatohepatitis, metabolic dysfunction-associated steatotic liver disease	Active, not recruiting	Phase 3	2026-06-01		NCT03900429